INFLUENZA VIRUS A AND B, ANTIGEN DETECTION

Test Code
LAB1051


Quest Code
11177


CPT Codes
87804 (x2)

Preferred Specimen
Nasopharyngeal (NP) swab collected in VCM medium or equivalent FDA approved transport media, Amies Liquid Transport Swab, Amies Liquid Elution Swab (ESwab™) or equivalent, or 1 mL saline
or
Nasopharyngeal washes/aspirate or lower nasal(turbinate) washes collected in VCM medium or equivalent FDA approved transport media


Minimum Volume
One swab or 1 mL


Other Acceptable Specimens
Throat swab


Instructions
NP swabs: Flocked nylon, Dacron® polyester or rayon-tipped swabs with flexible wire are recommended.
Washes and aspirates: Should be added to an equal amount of VCM medium


Transport Container
NP swabs: VCM medium or equivalent FDA approved transport media, Amies Liquid Transport Swab, Amies Liquid Elution Swab (ESwab) or equivalent, or 1 mL saline Washes and aspirates: VCM medium or equivalent FDA approved transport media.


Transport Temperature
Refrigerated (cold packs)


Specimen Stability
VCM or equivalent
Room temperature: Unacceptable
Refrigerated: 72 hours
Frozen: 6 months

Transport swab or saline
Room temperature: Unacceptable
Refrigerated: 72 hours
Frozen: Unacceptable


Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Specimens submitted in transport systems not listed as acceptable • Sources other than those listed as preferred or acceptable • Wooden-shaft swabs • Cotton tipped swabs • Calcium alginate swabs


Methodology
Optical Immunoassay

Setup Schedule
Mon-Sat


Report Available
3 days


Reference Range
Influenza A AntigenNot detected
Influenza B AntigenNot detected


Clinical Significance
Influenza is an acute viral disease that is seasonal in incidence, occurring in the colder months. The illness classically presents with sudden onset of fever, chills, headache, myalgia and a non-productive cough. Influenza A or B virus cause the majority of clinically significant disease, with influenza C virus being responsible only for mild, predominately upper respiratory tract illness. Patients who present with suspected influenza may benefit from treatment with antiviral agents. Since the therapeutic options have expanded to include options for the treatment of influenza B disease, it is important to rapidly distinguish influenza A from influenza B in order to allow physicians a choice in selective antiviral intervention. This will also allow for the appropriate preventative intervention to be taken in institutions where measures can be taken for susceptible individuals. It is therefore important to not only rapidly determine whether influenza is present, but also which type of influenza virus is present.


Performing Laboratory
Quest Diagnostics-Lenexa
10101 Renner Blvd
Lenexa , KS 66219-9752



Last Updated: August 13, 2021


The CPT Codes provided in this document are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payor being billed. Any Profile/panel component may be ordered separately. Reflex tests are performed at an additional charge.